New trial shows cancer vaccine cuts risk of melanoma returning @CBCTheNational
New trial shows cancer vaccine cuts risk of melanoma returning  @CBCTheNational
Uploaded October 2026 | Updated November 2026, 5 days ago
An experimental mRNA cancer vaccine from drug makers Merck and Moderna appears to help cut the chances of a melanoma tumour returning, according to the results of a new clinical trial.

The National is the flagship of CBC News showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault, our team of trusted reporters helps you make sense of the world, wherever you are.

Subscribe to get the latest news daily, and watch live starting at 9 p.m. ET.
youtube.com/user/CBCTheNational?sub_confirmation=1

More from CBC News | cbc.ca/news
New trial shows cancer vaccine cuts risk of melanoma returningTrump threatens more countries as uncertainty grows in VenezuelaAlberta tables bills to change health care, restrict gender-affirming care, sex-edHis dads WW II diary was brought to life through music | The Moment#TheMoment she became the 1st woman to solo the Worlds Toughest RowTrudeau hoped Freeland would stay on as deputy PMSeverely burned CFB Wainwright survivors treated with spray-on skin productNDP MP crossing floor to Liberals, party saysMajor winter storm wreaks havoc across U.S.Doug Ford, Danielle Smith join calls to turn North American trade pact into bilateral dealsGreenland isn’t taking Trump’s takeover threat seriously — yetCanadas forgotten war: Afghanistan 25 years later
CBC News: The National |

New trial shows cancer vaccine cuts risk of melanoma returning

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER